These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 19920976)

  • 1. Review of the safety, efficacy and patient acceptability of the levonorgestrel-releasing intrauterine system.
    Kailasam C; Cahill D
    Patient Prefer Adherence; 2008 Feb; 2():293-302. PubMed ID: 19920976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The levonorgestrel-releasing intrauterine system: an updated review of the contraceptive and noncontraceptive uses.
    Chrisman C; Ribeiro P; Dalton VK
    Clin Obstet Gynecol; 2007 Dec; 50(4):886-97. PubMed ID: 17982331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A risk-benefit assessment of the levonorgestrel-releasing intrauterine system.
    Sturridge F; Guillebaud J
    Drug Saf; 1996 Dec; 15(6):430-40. PubMed ID: 8968696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties.
    Luukkainen T; Toivonen J
    Contraception; 1995 Nov; 52(5):269-76. PubMed ID: 8585882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canadian Contraception Consensus (Part 3 of 4): Chapter 7--Intrauterine Contraception.
    Black A; Guilbert E; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman W; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; Mansouri S
    J Obstet Gynaecol Can; 2016 Feb; 38(2):182-222. PubMed ID: 27032746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormonal intrauterine devices.
    Rybo G; Andersson K; Odlind V
    Ann Med; 1993 Apr; 25(2):143-7. PubMed ID: 8489751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The levonorgestrel-releasing intrauterine system: Safety, efficacy, and patient acceptability.
    Beatty MN; Blumenthal PD
    Ther Clin Risk Manag; 2009 Jun; 5(3):561-74. PubMed ID: 19707273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levonorgestrel intrauterine device in the treatment of menorrhagia in Chinese women: efficacy versus acceptability.
    Tang GW; Lo SS
    Contraception; 1995 Apr; 51(4):231-5. PubMed ID: 7796588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomised comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagia.
    Irvine GA; Campbell-Brown MB; Lumsden MA; Heikkilä A; Walker JJ; Cameron IT
    Br J Obstet Gynaecol; 1998 Jun; 105(6):592-8. PubMed ID: 9647148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canadian Contraception Consensus (Part 2 of 4).
    Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N
    J Obstet Gynaecol Can; 2015 Nov; 37(11):1033-9. PubMed ID: 26629725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Canadian Contraception Consensus (Part 1 of 4).
    Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N;
    J Obstet Gynaecol Can; 2015 Oct; 37(10):936-42. PubMed ID: 26606712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of flurbiprofen, tranexamic acid, and a levonorgestrel-releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia.
    Milsom I; Andersson K; Andersch B; Rybo G
    Am J Obstet Gynecol; 1991 Mar; 164(3):879-83. PubMed ID: 1900665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of adenomyosis-associated menorrhagia with a levonorgestrel-releasing intrauterine device.
    Fedele L; Bianchi S; Raffaelli R; Portuese A; Dorta M
    Fertil Steril; 1997 Sep; 68(3):426-9. PubMed ID: 9314908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-contraceptive benefits of hormonal and intrauterine reversible contraceptive methods.
    Bahamondes L; Valeria Bahamondes M; Shulman LP
    Hum Reprod Update; 2015; 21(5):640-51. PubMed ID: 26037216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
    Lethaby A; Hussain M; Rishworth JR; Rees MC
    Cochrane Database Syst Rev; 2015 Apr; (4):CD002126. PubMed ID: 25924648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefit-risk assessment of the levonorgestrel intrauterine system in contraception.
    Backman T
    Drug Saf; 2004; 27(15):1185-204. PubMed ID: 15588115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levonorgestrel-releasing intrauterine system: uses and controversies.
    Bahamondes L; Bahamondes MV; Monteiro I
    Expert Rev Med Devices; 2008 Jul; 5(4):437-45. PubMed ID: 18573044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety, efficacy and patient acceptability of the contraceptive and non-contraceptive uses of the LNG-IUS.
    Bednarek PH; Jensen JT
    Int J Womens Health; 2010 Aug; 1():45-58. PubMed ID: 21072274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
    Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
    Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.